The Trial in Progress poster includes an overview and study design of the TACTI-004 Phase III evaluating the Company’s MHC Class II agonist, eftilagimod alfa (efti) in combination with MSD’s (Merck & ...

Immutep (IMMP) announces an upcoming poster presentation for the TACTI-004 Phase III trial. The poster will be presented at the European Lung ...

Seventy-one University of Kentucky students will present their research at the National Conference on Undergraduate Research ...

IceCure Medical Ltd.  ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an alternative to surgical tumor ...

In April 2024, Barinthus Bio announced topline results from the Phase 1b/2 APOLLO dose-ranging trial (also known as HPV001) ...

Eastern Michigan University's Undergraduate Symposium, scheduled to take place in the Student Center on March 28, 2025, ...

Multiple Redditors agreed that marketing was almost certainly behind the design. Shopper outraged after discovering deceptive ...

Strategic transformation ongoing, positioning the Company as a focused leader in immunology and inflammatory diseasesHighly differentiated, potentially curative immunotherapy for celiac disease (VTP-1 ...

America needs 90,000 more family doctors. Students who are currently in medical school have different priorities.

What drew you to pursue a career in oncology and what is it that inspires you most about working in this field?

This will help us to design population-based prostate cancer screening programmes that encourage higher rates of informed participation. Tackling attendance rates in this way could be a big factor ...